Our Mission

Napo Pharmaceuticals, a wholly-owned subsidiary of San Francisco-based Jaguar Health, Inc., focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace — every country, every population, every channel — regardless of social or economic status. Napo’s mission is to provide novel medicines to high-margin western markets, while leveraging economies of scale in emerging and developing markets.


Crofelemer is extracted and purified from sangre de drago, the bark sap of the Croton lechleri tree, which is an abundant, fast-growing Amazonian pioneer tree species widespread in Colombia, Ecuador, Peru, and Bolivia and is used by traditional healers working with medicinal plants in these areas. The bark sap, also known as latex, is sustainably harvested utilizing fair trade practices by local peoples who have been collaborating with Napo and our local partners over the past two decades with the aim of ensuring a high degree of quality and ecological integrity. Napo’s sustainable harvesting programs have a benefit of sequestering CO2.

Healing Forest Conservancy

healing forest logoThe Healing Forest Conservancy (HFC) is an independent non-profit foundation established in 1990 to specifically develop and implement a process to return benefits from product profits to collaborating countries and cultural groups after a product is commercialized, and for as long as Napo has a profit. These long-term benefits will be a percentage of all Napo’s products profits.

The mission of the HFC is to promote the conservation of the biological diversity of tropical forests, particularly medicinal plants, and the survival of the cultural diversity of tropical forest peoples, particularly their traditional knowledge of medicinal plants. The Conservancy will distribute these long-term benefits, equally, to all the countries and cultures that are Napo collaborators worldwide, regardless of where the plant sample or traditional knowledge originated. Trust funds are the financial mechanisms through which long-term revenues will be disbursed to the participating communities, regardless of the origin of the product.